World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: German Clinical Trials Register
Last refreshed on: 8 April 2024
Main ID:  DRKS00012317
Date of registration: 06/09/2017
Prospective Registration: Yes
Primary sponsor: Katholische Universität Eichstätt-Ingolstadt
Public title: Treating Prolonged Grief Disorder with Prolonged Grief-Specific Cognitive Behavioral Therapy: A Multicenter Parallel Group Randomized Controlled Trial
Scientific title: Treating Prolonged Grief Disorder with Prolonged Grief-Specific Cognitive Behavioral Therapy: A Multicenter Parallel Group Randomized Controlled Trial - PROGRID
Date of first enrolment: 26/10/2017
Target sample size: 204
Recruitment status: Complete
URL:  http://drks.de/search/en/trial/DRKS00012317
Study type:  interventional
Study design:  Allocation: Randomized controlled study; Masking: Blinded (masking used); Control: active; Assignment: parallel; Study design purpose: treatment  
Phase:  N/A
Countries of recruitment
Germany
Contacts
Name: Anna-Maria    Rummel
Address:  Levelingstr. 7 85049 Ingolstadt Germany
Telephone: +49 0841 937 - 21622
Email: Anna-Maria.Rummel@ku.de
Affiliation:  Katholische Universität Eichstätt-Ingolstadt, Lehrstuhl für Klinische und Biologische Psychologie
Name: Rita    Rosner
Address:  Ostenstr. 25 85072 Eichstätt Germany
Telephone: +49 8421 93 - 21581
Email: rita.rosner@ku.de
Affiliation:  Katholische Universität Eichstätt-Ingolstadt; Lehrstuhl Klinische und Biologische Psychologie
Key inclusion & exclusion criteria
Inclusion criteria: - primary diagnosis of prolonged grief disorder (PGD) as assessed in the PG-13 interview (Prigerson, Horowitz, Jacobs et al., 2009; German version: Rosner, Pfoh & Kotoucová, 2015)
- sufficient cognitive skills
- sufficient German language skills
- informed consent

Exclusion criteria: - current psychotic disorder
- severe substance use disorder
- acute suicidality
- ongoing psychotherapy
- treatment regime for antidepressant medication not yet stable for four weeks
- continuous treatment with benzodiazepines, antipsychotics, or opioids
- participation in another treatment trial


Age minimum: 18 Years
Age maximum: 75 Years
Gender: All
Health Condition(s) or Problem(s) studied
Prolonged grief disorder (PGD) – expected to be included in ICD-11 (see beta version: http://bit.ly/1GoZamZ)
Intervention(s)
Group 1: 20 to 24 individual sessions of integrative cognitive behavioral therapy for prolonged grief (PG-CBT; Pfoh, Kotoucová & Rosner, 2015). Sessions are scheduled weekly whenever possible, a session lasting 50 minutes, although some sessions can be combined (100 min). The overall length of treatment is about 6 months.
Group 2: 20 to 24 individual sessions of present-centered therapy (PCT; Schnurr, Friedman, Foy et al., 2003; Shea, Bernardy, Howard, Key, & Lambert, 2003). Sessions are scheduled weekly whenever possible, a session lasting 50 minutes, although some sessions can be combined (100 min). The overall length of treatment is about 6 months.
Primary Outcome(s)
Severity of prolonged grief symptoms 12 months after randomization, measured with the German version (Rosner, Pfoh & Kotoucová, 2015) of the Interview for Prolonged Grief-13 (PG-13; Prigerson, Horowitz, Jacobs et al., 2009)
Secondary Outcome(s)
Post-treatment:
Prolonged grief symptom severity, measured with the German version (Rosner, Pfoh & Kotoucová, 2015) of the Interview for Prolonged Grief-13 (PG-13; Prigerson, Horowitz, Jacobs et al., 2009)

12 months after randomization and post-treatment:
• overall mental health, measured with the Global Severity Index (GSI) of the German version of the Brief Symptom Inventory (BSI; Franke, 2000)
• depressive symptoms, measured with the German revised version of the Beck Depression Inventory (BDI-II; Hautzinger, Keller, & Kühner, 2009)
• severity of somatoform symptoms according to the SOMS-7 (Rief & Hiller, 2008)
Secondary ID(s)
Source(s) of Monetary Support
Deutsche Forschungsgemeinschaft
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 27/01/2017
Contact:
ethikkommission@ku.de
Ethikkommission der KU Eichstätt-Ingolstadt
+49 8421 93-21278
ethikkommission@ku.de
Results
Results available:
Date Posted:
Date Completed:
URL: http://drks.de/search/en/trial/DRKS00012317#studyResults
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history